NO318599B1 - Farmasoytisk preparat som inneholder tiagabin og fremgangsmate for dets fremstilling - Google Patents

Farmasoytisk preparat som inneholder tiagabin og fremgangsmate for dets fremstilling Download PDF

Info

Publication number
NO318599B1
NO318599B1 NO19975076A NO975076A NO318599B1 NO 318599 B1 NO318599 B1 NO 318599B1 NO 19975076 A NO19975076 A NO 19975076A NO 975076 A NO975076 A NO 975076A NO 318599 B1 NO318599 B1 NO 318599B1
Authority
NO
Norway
Prior art keywords
tiagabine
tocopherol
pharmaceutically acceptable
tiagabine hydrochloride
preparation
Prior art date
Application number
NO19975076A
Other languages
English (en)
Norwegian (no)
Other versions
NO975076L (no
NO975076D0 (no
Inventor
Helle Weibel
Thyge Borup Hjorth
Jorgen Ryhl Svensson
Lars Nygaard
Tina Meinertz Andersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO975076L publication Critical patent/NO975076L/no
Publication of NO975076D0 publication Critical patent/NO975076D0/no
Publication of NO318599B1 publication Critical patent/NO318599B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19975076A 1995-05-05 1997-11-04 Farmasoytisk preparat som inneholder tiagabin og fremgangsmate for dets fremstilling NO318599B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK52395 1995-05-05
PCT/DK1996/000192 WO1996034606A1 (en) 1995-05-05 1996-04-29 Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation

Publications (3)

Publication Number Publication Date
NO975076L NO975076L (no) 1997-11-04
NO975076D0 NO975076D0 (no) 1997-11-04
NO318599B1 true NO318599B1 (no) 2005-04-18

Family

ID=8094516

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975076A NO318599B1 (no) 1995-05-05 1997-11-04 Farmasoytisk preparat som inneholder tiagabin og fremgangsmate for dets fremstilling

Country Status (26)

Country Link
US (1) US5866590A (cs)
EP (1) EP0830132B1 (cs)
JP (1) JP3195360B2 (cs)
KR (1) KR100440354B1 (cs)
CN (1) CN1092959C (cs)
AR (1) AR003418A1 (cs)
AT (1) ATE211911T1 (cs)
AU (1) AU707508B2 (cs)
BR (1) BR9608120A (cs)
CA (1) CA2220019C (cs)
CZ (1) CZ292256B6 (cs)
DE (1) DE69618586T2 (cs)
DK (1) DK0830132T3 (cs)
EG (1) EG23781A (cs)
ES (1) ES2171669T3 (cs)
HU (1) HU223075B1 (cs)
IL (1) IL118142A (cs)
MX (1) MX9708394A (cs)
MY (1) MY115016A (cs)
NO (1) NO318599B1 (cs)
NZ (1) NZ307159A (cs)
PL (1) PL183678B1 (cs)
PT (1) PT830132E (cs)
UA (1) UA43402C2 (cs)
WO (1) WO1996034606A1 (cs)
ZA (1) ZA963478B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
JP2001511450A (ja) * 1997-08-01 2001-08-14 エラン コーポレーシヨン ピーエルシー チアガビンを含有する制御放出性の医薬組成物
EP1017386A1 (en) * 1997-10-02 2000-07-12 H. Lundbeck A/S GRANULAR PREPARATIONS OF 5-(2-ETHYL- 2$i(H)-TETRAZOL- 5-YL)-1-METHYL-1, 2,3,6-TETRAHYDROPYRIDINE
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
ZA99407B (en) * 1998-01-22 1999-07-20 Abbott Lab Extended release tiagabine formulations with reduced side-effects.
AU2002325404B2 (en) * 1998-01-22 2006-02-02 Abbott Laboratories Extended Release Tiagabine Formulations with Reduced Side-effects
EP1303273A1 (en) * 2000-05-26 2003-04-23 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
AU2000249111A1 (en) * 2000-05-30 2001-12-11 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
WO2006067605A1 (en) * 2004-12-23 2006-06-29 Ranbaxy Laboratories Limited Stable pharmaceutical compositions of tiagabine and processes for their preparation
CN102125693A (zh) * 2011-01-25 2011-07-20 福建科瑞药业有限公司 一种盐酸噻加宾药物组合物及其制备方法
SG11201407309XA (en) * 2012-05-08 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of epilepsy
WO2017038612A1 (ja) * 2015-08-28 2017-03-09 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US501090A (en) * 1893-07-11 gennert
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
FR2698788B1 (fr) 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies

Also Published As

Publication number Publication date
MX9708394A (es) 1998-02-28
ES2171669T3 (es) 2002-09-16
NO975076L (no) 1997-11-04
ATE211911T1 (de) 2002-02-15
AU5644196A (en) 1996-11-21
EP0830132A1 (en) 1998-03-25
AR003418A1 (es) 1998-08-05
MY115016A (en) 2003-03-31
IL118142A (en) 1999-11-30
NZ307159A (en) 1998-10-28
PL323138A1 (en) 1998-03-16
WO1996034606A1 (en) 1996-11-07
EP0830132B1 (en) 2002-01-16
UA43402C2 (uk) 2001-12-17
DK0830132T3 (da) 2002-04-29
DE69618586T2 (de) 2002-09-05
CZ292256B6 (cs) 2003-08-13
CN1092959C (zh) 2002-10-23
EG23781A (en) 2007-08-13
HUP9802741A3 (en) 1999-04-28
PL183678B1 (pl) 2002-06-28
CZ338897A3 (cs) 1998-03-18
CA2220019C (en) 2007-12-11
AU707508B2 (en) 1999-07-15
JP3195360B2 (ja) 2001-08-06
CA2220019A1 (en) 1996-11-07
KR100440354B1 (ko) 2004-09-18
PT830132E (pt) 2002-07-31
HUP9802741A2 (hu) 1999-03-29
BR9608120A (pt) 1999-02-09
NO975076D0 (no) 1997-11-04
ZA963478B (en) 1996-11-13
JPH10505359A (ja) 1998-05-26
DE69618586D1 (de) 2002-02-21
IL118142A0 (en) 1996-09-12
HU223075B1 (hu) 2004-03-01
US5866590A (en) 1999-02-02
CN1183721A (zh) 1998-06-03

Similar Documents

Publication Publication Date Title
CN104383542B (zh) 包含甲基纳曲酮的药物配方
NO318599B1 (no) Farmasoytisk preparat som inneholder tiagabin og fremgangsmate for dets fremstilling
EP0673245A1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofene et son procede de preparation.
EP4410793A1 (en) Solid composition of glp-1 receptor agonist
MX2012008516A (es) Agonista alfa-2 adrenergico que tiene larga duracion de efecto de baja presion intraocular.
MXPA97008394A (en) Pharmaceutical composition containing tiagabin chlorhydrate and the process for its preparation
JP2003055258A (ja) 安定化された組成物
EP3530289B1 (en) Oral pharmaceutical solutions comprising melatonin
SK286194B6 (sk) Vodná farmaceutická zmes
AU2022240348A1 (en) Liquid preparation of l-serine or pharmaceutically acceptable salt thereof and method for preparing same
US7439248B1 (en) Pharmaceutical composition and the process for its preparation
JP2003055223A (ja) 安定化された組成物
AU2019269123A1 (en) A stable aqueous hydroxycarbamide solution
RU2173996C2 (ru) Фармацевтическая композиция, содержащая гидрохлорид тиагабина, и способ ее получения
CN110711174A (zh) 一种泊沙康唑注射液中间体溶液配制方法
JP2003055222A (ja) 安定化された組成物
RU2419417C1 (ru) Фармацевтическая композиция в виде раствора флуконазола, обладающая противогрибковым действием
EP3492083A1 (en) Solid preparation having improved light stability
JP2003055224A (ja) 安定化された組成物
EP4268825A1 (en) Pharmaceutical composition for transdermal administration containing epinastine or salt thereof and containing sulfur-based antioxidant
JP2003055225A (ja) 安定化された組成物
EP4628082A1 (en) Pharmaceutical composition of kappa opioid receptor agonist, preparation method therefor, and use thereof
KR20190070053A (ko) 다파글리플로진 유리염기를 함유하는 약제학적 조성물 및 이의 제조방법
TWI334862B (cs)
EP4420664A1 (en) Pharmaceutical composition comprising cytisine

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees